Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC, 34651-34655 [2020-12177]
Download as PDF
<![CDATA[
34651
Federal Register / Vol. 85, No. 109 / Friday, June 5, 2020 / Notices
(iv) indicate whether complainant,
complainant’s licensees, and/or third
party suppliers have the capacity to
replace the volume of articles
potentially subject to the requested
exclusion order and/or a cease and
desist order within a commercially
reasonable time; and
(v) explain how the requested
remedial orders would impact United
States consumers.
Written submissions on the public
interest must be filed no later than by
close of business, eight calendar days
after the date of publication of this
notice in the Federal Register. There
will be further opportunities for
comment on the public interest after the
issuance of any final initial
determination in this investigation. Any
written submissions on other issues
must also be filed by no later than the
close of business, eight calendar days
after publication of this notice in the
Federal Register. Complainant may file
replies to any written submissions no
later than three calendar days after the
date on which any initial submissions
were due. Any submissions and replies
filed in response to this Notice are
limited to five (5) pages in length,
inclusive of attachments.
Persons filing written submissions
must file the original document
electronically on or before the deadlines
stated above and submit 8 true paper
copies to the Office of the Secretary by
noon the next day pursuant to § 210.4(f)
of the Commission’s Rules of Practice
and Procedure (19 CFR 210.4(f)).
Submissions should refer to the docket
number (‘‘Docket No. 3457’’) in a
prominent place on the cover page and/
or the first page. (See Handbook for
Electronic Filing Procedures, Electronic
Filing Procedures 1). Persons with
questions regarding filing should
contact the Secretary (202–205–2000).
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel,2 solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
SUPPLEMENTARY INFORMATION:
By order of the Commission.
Issued: June 1, 2020.
Lisa Barton,
Secretary to the Commission.
Drug Enforcement Administration
Controlled substance
JWH–018 (also known as
AM678) 7118 I N 1-Pentyl3-(1-naphthoyl)indole.
lotter on DSK9F5VC42PROD with NOTICES
18:21 Jun 04, 2020
Jkt 250001
BILLING CODE 7020–02–P
[FR Doc. 2020–12180 Filed 6–4–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Bulk Manufacturer of Controlled
Substances Application: Chemtos,
LLC
ACTION:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–659]
Bulk Manufacturer of Controlled
Substances Application: Sigma Aldrich
Research Biochemicals, Inc.
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 4, 2020.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 4, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on May 7, 2020, Chemtos,
LLC, 16713 Picadilly Court, Round
Rock, Texas 78664–8544, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substances:
SUPPLEMENTARY INFORMATION:
Drug code
2 All contract personnel will sign appropriate
nondisclosure agreements.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
I
William T. McDermott,
Assistant Administrator.
3-Fluoro-N-methylcathinone (3–FMC) .............................................................................................................................
Cathinone ........................................................................................................................................................................
Methcathinone .................................................................................................................................................................
VerDate Sep<11>2014
7118
Schedule
The company plans to manufacture
small quantities of the listed controlled
substance to make reference standards
for distribution to its customers.
Controlled substance
1 Handbook for Electronic Filing Procedures:
https://www.usitc.gov/documents/handbook_on_
filing_procedures.pdf.
Drug
code
[Docket No. DEA–655]
[FR Doc. 2020–12151 Filed 6–4–20; 8:45 am]
ACTION:
In
accordance with 21 CFR 1301.33(a), this
is notice that on May 4, 2020, Sigma
Aldrich Research Biochemicals, Inc.,
400–600 Summit Drive, Burlington,
Massachusetts 01803, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance:
1233
1235
1237
Schedule
I
I
I
3 Electronic Document Information System
(EDIS): https://edis.usitc.gov.
E:\FR\FM\05JNN1.SGM
05JNN1
34652
Federal Register / Vol. 85, No. 109 / Friday, June 5, 2020 / Notices
lotter on DSK9F5VC42PROD with NOTICES
Controlled substance
Drug code
4-Fluoro-N-methylcathinone (4–FMC) .............................................................................................................................
Pentedrone (a-methylaminovalerophenone) ...................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
4-Methyl-N-ethylcathinone (4–MEC) ...............................................................................................................................
Naphyrone .......................................................................................................................................................................
N-Ethylamphetamine .......................................................................................................................................................
N,N-Dimethylamphetamine ..............................................................................................................................................
Fenethylline .....................................................................................................................................................................
Aminorex ..........................................................................................................................................................................
4-Methylaminorex (cis isomer) ........................................................................................................................................
Gamma Hydroxybutyric Acid ...........................................................................................................................................
Methaqualone ..................................................................................................................................................................
Mecloqualone ..................................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ..................................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ................................................
ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .............
5–Fluoro–UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl] (2,2,3,3-tetramethylcyclopropyl)methanone .............
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .....................
FUB–144 (1-(4-fluorobenzyl)-1H-indol-3-yl) (2,2,3,3-tetramethylcyclopropyl)methanone) .............................................
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ......................................................................................................................
MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ......................
FUB–AMB, MMB–FUBINACA, AMB–FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3methylbutanoate).
AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .........................................
THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ...................................................................
5F–AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) ........................
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide .................
MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ........
5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ..............................................
5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ......
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .................................
5F–EDMB–PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .........................
5F–MDMB–PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ..............................
MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3dimethylbutanoate).
MMB–CHMICA, AMB–CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) ........
FUB–AKB48, FUB–APINACA, AKB48 N-(4–FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole3-carboximide).
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ..............................................................
5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ..................................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ..................................................................................................
5F–CUMYL–PINACA, 5GT–25 (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) ....................
5F–CUMYL–P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) ...............
4–CN–CUML–BUTINACA, 4–cyano–CUMYL–BUTINACA, 4–CN–CUMYL BINACA, CUMYL–4CN–BINACA, SGT–
78 (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide).
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ....................................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ..............................................................................
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) .....................................................................................................
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .................................................................
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) .......................................................................................................................
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ..........................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) .......................................................................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ......................................................................................................
NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate ..........................................................
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) .................................................................................................
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ............................................................................
4–MEAP (4-Methyl-alpha-ethylaminopentiophenone) .....................................................................................................
N-Ethylhexedrone ............................................................................................................................................................
Alpha-ethyltryptamine ......................................................................................................................................................
Ibogaine ...........................................................................................................................................................................
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ..........................................
Lysergic acid diethylamide ..............................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) ..............................................................................................
Marihuana Extract ...........................................................................................................................................................
Marihuana ........................................................................................................................................................................
Parahexyl .........................................................................................................................................................................
Mescaline .........................................................................................................................................................................
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2 ) ..........................................................................................
3,4,5-Trimethoxyamphetamine ........................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .............................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..........................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .............................................................................................................................
2,5-Dimethoxyamphetamine ............................................................................................................................................
VerDate Sep<11>2014
18:21 Jun 04, 2020
Jkt 250001
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
E:\FR\FM\05JNN1.SGM
05JNN1
Schedule
1238
1246
1248
1249
1258
1475
1480
1503
1585
1590
2010
2565
2572
6250
7008
7010
7011
7012
7014
7019
7020
7021
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
7023
7024
7025
7031
7032
7033
7034
7035
7036
7041
7042
I
I
I
I
I
I
I
I
I
I
I
7044
7047
I
I
7048
7049
7081
7083
7085
7089
I
I
I
I
I
I
7104
7118
7122
7144
7173
7200
7201
7203
7221
7222
7225
7245
7246
7249
7260
7297
7298
7315
7348
7350
7360
7374
7381
7385
7390
7391
7392
7395
7396
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
34653
Federal Register / Vol. 85, No. 109 / Friday, June 5, 2020 / Notices
lotter on DSK9F5VC42PROD with NOTICES
Controlled substance
Drug code
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ......................................................................................................
2,5-Dimethoxy-4-ethylamphetamine ................................................................................................................................
3,4-Methylenedioxyamphetamine ....................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ..................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ..................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine .......................................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
4-Methoxyamphetamine ..................................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine .................................................................................................................................
Alpha-methyltryptamine ...................................................................................................................................................
Bufotenine ........................................................................................................................................................................
Diethyltryptamine .............................................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
Psilocybin .........................................................................................................................................................................
Psilocyn ...........................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine .............................................................................................................................
4′-Chloro-alpha-pyrrolidinovalerophenone .......................................................................................................................
MPHP, 4′-Methyl-alpha-pyrrolidinohexiophenone ...........................................................................................................
N-Ethyl-1-phenylcyclohexylamine ....................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ....................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ...............................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ..............................................................................................................................
N-Ethyl-3-piperidyl benzilate ............................................................................................................................................
N-Methyl-3-piperidyl benzilate .........................................................................................................................................
N-Benzylpiperazine ..........................................................................................................................................................
4-Methyl-alphapyrrolidinopropiophenone (4–MePPP) .....................................................................................................
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) ..................................................................................................
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E ) ....................................................................................................
2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) .................................................................................................................
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) ........................................................................................................
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C–C) ..................................................................................................
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) ....................................................................................................
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) .............................................................................................
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4 ) ..................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) .......................................................................................................................
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) ....................................................
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) ....................................................
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) .........................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ......................................................................................................
Butylone ...........................................................................................................................................................................
Pentylone .........................................................................................................................................................................
N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) .....................................................
a-PHP, alpha-Pyrrolidinohexanophenone .......................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) ........................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) ..........................................................................................................................
alpha-pyrrolidinoheptaphenone (PV8) .............................................................................................................................
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ...................................................................................................
Acetyldihydrocodeine .......................................................................................................................................................
Benzylmorphine ...............................................................................................................................................................
Codeine-N-oxide ..............................................................................................................................................................
Cyprenorphine .................................................................................................................................................................
Desomorphine .................................................................................................................................................................
Etorphine (except HCl) ....................................................................................................................................................
Codeine methylbromide ...................................................................................................................................................
Dihydromorphine .............................................................................................................................................................
Difenoxin ..........................................................................................................................................................................
Heroin ..............................................................................................................................................................................
Hydromorphinol ...............................................................................................................................................................
Methyldesorphine ............................................................................................................................................................
Methyldihydromorphine ...................................................................................................................................................
Morphine methylbromide .................................................................................................................................................
Morphine methylsulfonate ...............................................................................................................................................
Morphine-N-oxide ............................................................................................................................................................
Myrophine ........................................................................................................................................................................
Nicocodeine .....................................................................................................................................................................
Nicomorphine ...................................................................................................................................................................
Normorphine ....................................................................................................................................................................
Pholcodine .......................................................................................................................................................................
Thebacon .........................................................................................................................................................................
Acetorphine ......................................................................................................................................................................
Drotebanol .......................................................................................................................................................................
U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ..............................................................
AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ..................................................................
MT–45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) ..................................................................................................
VerDate Sep<11>2014
18:21 Jun 04, 2020
Jkt 250001
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
E:\FR\FM\05JNN1.SGM
05JNN1
7398
7399
7400
7401
7402
7404
7405
7411
7431
7432
7433
7434
7435
7437
7438
7439
7443
7446
7455
7458
7470
7473
7482
7484
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7543
7544
7545
7546
7548
7694
9051
9052
9053
9054
9055
9056
9070
9145
9168
9200
9301
9302
9304
9305
9306
9307
9308
9309
9312
9313
9314
9315
9319
9335
9547
9551
9560
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
34654
Federal Register / Vol. 85, No. 109 / Friday, June 5, 2020 / Notices
lotter on DSK9F5VC42PROD with NOTICES
Controlled substance
Drug code
Acetylmethadol ................................................................................................................................................................
Allylprodine ......................................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol ......................................................................................................
Alphameprodine ...............................................................................................................................................................
Alphamethadol .................................................................................................................................................................
Benzethidine ....................................................................................................................................................................
Betacetylmethadol ...........................................................................................................................................................
Betameprodine ................................................................................................................................................................
Betamethadol ...................................................................................................................................................................
Betaprodine .....................................................................................................................................................................
Clonitazene ......................................................................................................................................................................
Dextromoramide ..............................................................................................................................................................
Diampromide ...................................................................................................................................................................
Diethylthiambutene ..........................................................................................................................................................
Dimenoxadol ....................................................................................................................................................................
Dimepheptanol .................................................................................................................................................................
Dimethylthiambutene .......................................................................................................................................................
Dioxaphetyl butyrate ........................................................................................................................................................
Dipipanone .......................................................................................................................................................................
Ethylmethylthiambutene ..................................................................................................................................................
Etonitazene ......................................................................................................................................................................
Etoxeridine .......................................................................................................................................................................
Furethidine .......................................................................................................................................................................
Hydroxypethidine .............................................................................................................................................................
Ketobemidone ..................................................................................................................................................................
Levomoramide .................................................................................................................................................................
Levophenacylmorphan ....................................................................................................................................................
Morpheridine ....................................................................................................................................................................
Noracymethadol ...............................................................................................................................................................
Norlevorphanol ................................................................................................................................................................
Normethadone .................................................................................................................................................................
Norpipanone ....................................................................................................................................................................
Phenadoxone ...................................................................................................................................................................
Phenampromide ..............................................................................................................................................................
Phenoperidine ..................................................................................................................................................................
Piritramide ........................................................................................................................................................................
Proheptazine ....................................................................................................................................................................
Properidine ......................................................................................................................................................................
Racemoramide ................................................................................................................................................................
Trimeperidine ...................................................................................................................................................................
Phenomorphan ................................................................................................................................................................
Propiram ..........................................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine ......................................................................................................................
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine ..............................................................................................................
Tilidine .............................................................................................................................................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) .................................................................................
Para-Fluorofentanyl .........................................................................................................................................................
3-Methylfentanyl ..............................................................................................................................................................
Alpha-methylfentanyl .......................................................................................................................................................
Acetyl-alpha-methylfentanyl .............................................................................................................................................
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide .......................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ...............................................................................
Butyryl Fentanyl ...............................................................................................................................................................
Para-fluorobutyryl fentanyl ...............................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) .........................................
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide .........................................................................................
Para-chloroisobutyryl fentanyl .........................................................................................................................................
Isobutyryl fentanyl ............................................................................................................................................................
Beta-hydroxyfentanyl .......................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ........................................................................................................................................
Alpha-methylthiofentanyl .................................................................................................................................................
3-Methylthiofentanyl .........................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .............................................................
Thiofentanyl .....................................................................................................................................................................
Beta-hydroxythiofentanyl .................................................................................................................................................
Para-methoxybutyryl fentanyl ..........................................................................................................................................
Para-methoxybutyryl fentanyl ..........................................................................................................................................
Valeryl fentanyl ................................................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ..........................................................................
Cyclopropyl Fentanyl .......................................................................................................................................................
Cyclopentyl Fentanyl .......................................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) .....................................................................................
Amphetamine ...................................................................................................................................................................
Methamphetamine ...........................................................................................................................................................
VerDate Sep<11>2014
18:21 Jun 04, 2020
Jkt 250001
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
E:\FR\FM\05JNN1.SGM
05JNN1
9601
9602
9603
9604
9605
9606
9607
9608
9609
9611
9612
9613
9615
9616
9617
9618
9619
9621
9622
9623
9624
9625
9626
9627
9628
9629
9631
9632
9633
9634
9635
9636
9637
9638
9641
9642
9643
9644
9645
9646
9647
9649
9661
9663
9750
9811
9812
9813
9814
9815
9816
9821
9822
9823
9824
9825
9826
9827
9830
9831
9832
9833
9834
9835
9836
9837
9838
9840
9843
9845
9847
9850
1100
1105
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
34655
Federal Register / Vol. 85, No. 109 / Friday, June 5, 2020 / Notices
Controlled substance
Drug code
Lisdexamfetamine ............................................................................................................................................................
Phenmetrazine .................................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
Secobarbital .....................................................................................................................................................................
Glutethimide .....................................................................................................................................................................
Nabilone ...........................................................................................................................................................................
1-Phenylcyclohexylamine ................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .....................................................................................................................
Phenylacetone .................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ................................................................................................................................
Alphaprodine ....................................................................................................................................................................
Anileridine ........................................................................................................................................................................
Cocaine ............................................................................................................................................................................
Codeine ...........................................................................................................................................................................
Etorphine HCl ..................................................................................................................................................................
Dihydrocodeine ................................................................................................................................................................
Oxycodone .......................................................................................................................................................................
Hydromorphone ...............................................................................................................................................................
Diphenoxylate ..................................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Ethylmorphine ..................................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Levomethorphan ..............................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Isomethadone ..................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Meperidine intermediate-A ..............................................................................................................................................
Meperidine intermediate-B ..............................................................................................................................................
Meperidine intermediate-C ..............................................................................................................................................
Metazocine ......................................................................................................................................................................
Methadone .......................................................................................................................................................................
Methadone intermediate ..................................................................................................................................................
Metopon ...........................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..............................................................................................................
Morphine ..........................................................................................................................................................................
Oripavine .........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Dihydroetorphine .............................................................................................................................................................
Levo-alphacetylmethadol .................................................................................................................................................
Oxymorphone ..................................................................................................................................................................
Noroxymorphone .............................................................................................................................................................
Phenazocine ....................................................................................................................................................................
Thiafentanil ......................................................................................................................................................................
Piminodine .......................................................................................................................................................................
Racemethorphan .............................................................................................................................................................
Racemorphan ..................................................................................................................................................................
Alfentanil ..........................................................................................................................................................................
Remifentanil .....................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
Carfentanil .......................................................................................................................................................................
Tapentadol .......................................................................................................................................................................
Bezitramide ......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
Moramide-intermediate ....................................................................................................................................................
lotter on DSK9F5VC42PROD with NOTICES
The company plans to manufacture
small quantities of the listed controlled
substances in bulk for distribution to its
customers.
[FR Doc. 2020–12177 Filed 6–4–20; 8:45 am]
BILLING CODE 4410–09–P
Drug Enforcement Administration
Bulk Manufacturer of Controlled
Substances Application: Nalas
Engineering Services, Inc.
ACTION:
VerDate Sep<11>2014
18:21 Jun 04, 2020
Jkt 250001
PO 00000
Notice of application.
Frm 00067
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 4, 2020.
DATES:
DEPARTMENT OF JUSTICE
[Docket No. DEA–657]
William T. McDermott,
Assistant Administrator.
1205
1631
1724
2125
2270
2315
2550
7379
7460
7471
8333
8501
8603
9010
9020
9041
9050
9059
9120
9143
9150
9170
9180
9190
9193
9210
9220
9226
9230
9232
9233
9234
9240
9250
9254
9260
9273
9300
9330
9333
9334
9648
9652
9668
9715
9729
9730
9732
9733
9737
9739
9740
9743
9780
9800
9801
9802
Schedule
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
E:\FR\FM\05JNN1.SGM
05JNN1
]]>Agencies
[Federal Register Volume 85, Number 109 (Friday, June 5, 2020)]
[Notices]
[Pages 34651-34655]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-12177]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-655]
Bulk Manufacturer of Controlled Substances Application: Chemtos,
LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before August 4, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on May 7, 2020, Chemtos, LLC, 16713 Picadilly Court,
Round Rock, Texas 78664-8544, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC)....... 1233 I
Cathinone................................ 1235 I
Methcathinone............................ 1237 I
[[Page 34652]]
4-Fluoro-N-methylcathinone (4-FMC)....... 1238 I
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
Mephedrone (4-Methyl-N-methylcathinone).. 1248 I
4-Methyl-N-ethylcathinone (4-MEC)........ 1249 I
Naphyrone................................ 1258 I
N-Ethylamphetamine....................... 1475 I
N,N-Dimethylamphetamine.................. 1480 I
Fenethylline............................. 1503 I
Aminorex................................. 1585 I
4-Methylaminorex (cis isomer)............ 1590 I
Gamma Hydroxybutyric Acid................ 2010 I
Methaqualone............................. 2565 I
Mecloqualone............................. 2572 I
JWH-250 (1-Pentyl-3-(2- 6250 I
methoxyphenylacetyl) indole).
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-
methoxyphenylacetyl) indole).
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1- 7010 I
oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide).
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro- 7011 I
pentyl)1H-indol-3-yl] (2,2,3,3-
tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1- 7012 I
oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide).
FUB-144 (1-(4-fluorobenzyl)-1H-indol-3- 7014 I
yl) (2,2,3,3-
tetramethylcyclopropyl)methanone).
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).. 7019 I
MDMB-FUBINACA (Methyl 2-(1-(4- 7020 I
fluorobenzyl)-1H-indazole-3-carboxamido)-
3,3-dimethylbutanoate).
FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1- 7021 I
(4-fluorobenzyl)-1Hindazole-3-
carboxamido)-3-methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan- 7023 I
2-yl)-1-pentyl-1H-indazole-3-
carboxamide).
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3- 7024 I
yl](naphthalen-1-yl)methanone.
5F-AB-PINACA (N-(1-amino-3-methyl-1- 7025 I
oxobutan-2-yl)-1-(5-fluropentyl)-1H-
indazole-3-carboximide).
AB-CHMINACA (N-(1-amino-3-methyl-1- 7031 I
oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
indazole-3-carboxamide.
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1- 7032 I
oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
indazole-3-carboxamide).
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H- 7033 I
indazole-3-carboxamido)-3-
methylbutanoate).
5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1-(5- 7034 I
fluoropentyl)-1H-indazole-3-carboxamido)-
3,3-dimethylbutanoate).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1- 7035 I
oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide).
5F-EDMB-PINACA (ethyl 2-(1-(5- 7036 I
fluoropentyl)-1H-indazole-3-carboxamido)-
3,3-dimethylbutanoate).
5F-MDMB-PICA (methyl 2-(1-(5- 7041 I
fluoropentyl)-1H-indole-3-carboxamido)-
3,3-dimethylbutanoate).
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1- 7042 I
(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3,3-dimethylbutanoate).
MMB-CHMICA, AMB-CHMICA (methyl 2-(1- 7044 I
(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3-methylbutanoate).
FUB-AKB48, FUB-APINACA, AKB48 N-(4- 7047 I
FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-
fluorobenzyl)-1H-indazole-3-carboximide).
APINACA and AKB48 N-(1-Adamantyl)-1- 7048 I
pentyl-1H-indazole-3-carboxamide.
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)- 7049 I
1-(5-fluoropentyl)-1H-indazole-3-
carboxamide).
JWH-081 (1-Pentyl-3-(1-(4- 7081 I
methoxynaphthoyl) indole).
5F-CUMYL-PINACA, 5GT-25 (1-(5- 7083 I
fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-
indazole-3-carboxamide).
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2- 7085 I
phenylpropan-2-yl)-1H-pyrrolo[2,3-
b]pyridine-3-carboxamide).
4-CN-CUML-BUTINACA, 4-cyano-CUMYL- 7089 I
BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-
BINACA, SGT-78 (1-(4-cyanobutyl)-N-(2-
phenylpropan-2-yl)-1H-indazole-3-
carboxamide).
SR-19 (Also known as RCS-4) (1-Pentyl-3- 7104 I
[(4-methoxy)-benzoyl] indole.
JWH-018 (also known as AM678) (1-Pentyl-3- 7118 I
(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I
naphthoyl) indole).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I
tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1-naphthoyl)indole).. 7173 I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- 7200 I
naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I
naphthoyl) indole).
JWH-203 (1-Pentyl-3-(2- 7203 I
chlorophenylacetyl) indole).
NM2201, CBL2201 (Naphthalen-1-yl 1-(5- 7221 I
fluoropentyl)-1H-indole-3-carboxylate.
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3- 7222 I
carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5- 7225 I
fluoropentyl)-1H-indole-3-carboxylate).
4-MEAP (4-Methyl-alpha- 7245 I
ethylaminopentiophenone).
N-Ethylhexedrone......................... 7246 I
Alpha-ethyltryptamine.................... 7249 I
Ibogaine................................. 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I
[(1R,3S)-3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol).
Lysergic acid diethylamide............... 7315 I
2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine (2C-T-7).
Marihuana Extract........................ 7350 I
Marihuana................................ 7360 I
Parahexyl................................ 7374 I
Mescaline................................ 7381 I
2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I
ethanamine (2C-T-2 ).
3,4,5-Trimethoxyamphetamine.............. 7390 I
4-Bromo-2,5-dimethoxyamphetamine......... 7391 I
4-Bromo-2,5-dimethoxyphenethylamine...... 7392 I
4-Methyl-2,5-dimethoxyamphetamine........ 7395 I
2,5-Dimethoxyamphetamine................. 7396 I
[[Page 34653]]
JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I
naphthoyl) indole).
2,5-Dimethoxy-4-ethylamphetamine......... 7399 I
3,4-Methylenedioxyamphetamine............ 7400 I
5-Methoxy-3,4-methylenedioxyamphetamine.. 7401 I
N-Hydroxy-3,4-methylenedioxyamphetamine.. 7402 I
3,4-Methylenedioxy-N-ethylamphetamine.... 7404 I
3,4-Methylenedioxymethamphetamine........ 7405 I
4-Methoxyamphetamine..................... 7411 I
5-Methoxy-N-N-dimethyltryptamine......... 7431 I
Alpha-methyltryptamine................... 7432 I
Bufotenine............................... 7433 I
Diethyltryptamine........................ 7434 I
Dimethyltryptamine....................... 7435 I
Psilocybin............................... 7437 I
Psilocyn................................. 7438 I
5-Methoxy-N,N-diisopropyltryptamine...... 7439 I
4'-Chloro-alpha-pyrrolidinovalerophenone. 7443 I
MPHP, 4'-Methyl-alpha- 7446 I
pyrrolidinohexiophenone.
N-Ethyl-1-phenylcyclohexylamine.......... 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine........ 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine.... 7470 I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine... 7473 I
N-Ethyl-3-piperidyl benzilate............ 7482 I
N-Methyl-3-piperidyl benzilate........... 7484 I
N-Benzylpiperazine....................... 7493 I
4-Methyl-alphapyrrolidinopropiophenone (4- 7498 I
MePPP).
2-(2,5-Dimethoxy-4-methylphenyl) 7508 I
ethanamine (2C-D).
2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I
ethanamine (2C-E ).
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) 7517 I
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine 7518 I
(2C-I).
2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I
ethanamine (2C-C).
2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I
ethanamine (2C-N).
2-(2,5-Dimethoxy-4-(n)-propylphenyl) 7524 I
ethanamine (2C-P).
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) 7532 I
ethanamine (2C-T-4 ).
MDPV (3,4-Methylenedioxypyrovalerone).... 7535 I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- 7536 I
methoxybenzyl) ethanamine (25B-NBOMe).
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- 7537 I
methoxybenzyl) ethanamine (25C-NBOMe).
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- 7538 I
methoxybenzyl) ethanamine (25I-NBOMe).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone................................. 7541 I
Pentylone................................ 7542 I
N-Ethypentylone, ephylone (1-(1,3- 7543 I
benzodioxol-5-yl)-2-(ethylamino)-pentan-
1-one).
[alpha]-PHP, alpha- 7544 I
Pyrrolidinohexanophenone.
alpha-pyrrolidinopentiophenone ([alpha]- 7545 I
PVP).
alpha-pyrrolidinobutiophenone ([alpha]- 7546 I
PBP).
alpha-pyrrolidinoheptaphenone (PV8)...... 7548 I
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl) indole).
Acetyldihydrocodeine..................... 9051 I
Benzylmorphine........................... 9052 I
Codeine-N-oxide.......................... 9053 I
Cyprenorphine............................ 9054 I
Desomorphine............................. 9055 I
Etorphine (except HCl)................... 9056 I
Codeine methylbromide.................... 9070 I
Dihydromorphine.......................... 9145 I
Difenoxin................................ 9168 I
Heroin................................... 9200 I
Hydromorphinol........................... 9301 I
Methyldesorphine......................... 9302 I
Methyldihydromorphine.................... 9304 I
Morphine methylbromide................... 9305 I
Morphine methylsulfonate................. 9306 I
Morphine-N-oxide......................... 9307 I
Myrophine................................ 9308 I
Nicocodeine.............................. 9309 I
Nicomorphine............................. 9312 I
Normorphine.............................. 9313 I
Pholcodine............................... 9314 I
Thebacon................................. 9315 I
Acetorphine.............................. 9319 I
Drotebanol............................... 9335 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]benzamide
)).
MT-45 (1-cyclohexyl-4-(1,2- 9560 I
diphenylethyl)piperazine)).
[[Page 34654]]
Acetylmethadol........................... 9601 I
Allylprodine............................. 9602 I
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.
Alphameprodine........................... 9604 I
Alphamethadol............................ 9605 I
Benzethidine............................. 9606 I
Betacetylmethadol........................ 9607 I
Betameprodine............................ 9608 I
Betamethadol............................. 9609 I
Betaprodine.............................. 9611 I
Clonitazene.............................. 9612 I
Dextromoramide........................... 9613 I
Diampromide.............................. 9615 I
Diethylthiambutene....................... 9616 I
Dimenoxadol.............................. 9617 I
Dimepheptanol............................ 9618 I
Dimethylthiambutene...................... 9619 I
Dioxaphetyl butyrate..................... 9621 I
Dipipanone............................... 9622 I
Ethylmethylthiambutene................... 9623 I
Etonitazene.............................. 9624 I
Etoxeridine.............................. 9625 I
Furethidine.............................. 9626 I
Hydroxypethidine......................... 9627 I
Ketobemidone............................. 9628 I
Levomoramide............................. 9629 I
Levophenacylmorphan...................... 9631 I
Morpheridine............................. 9632 I
Noracymethadol........................... 9633 I
Norlevorphanol........................... 9634 I
Normethadone............................. 9635 I
Norpipanone.............................. 9636 I
Phenadoxone.............................. 9637 I
Phenampromide............................ 9638 I
Phenoperidine............................ 9641 I
Piritramide.............................. 9642 I
Proheptazine............................. 9643 I
Properidine.............................. 9644 I
Racemoramide............................. 9645 I
Trimeperidine............................ 9646 I
Phenomorphan............................. 9647 I
Propiram................................. 9649 I
1-Methyl-4-phenyl-4-propionoxypiperidine. 9661 I
1-(2-Phenylethyl)-4-phenyl-4- 9663 I
acetoxypiperidine.
Tilidine................................. 9750 I
Acryl fentanyl (N-(1-phenethylpiperidin-4- 9811 I
yl)-N-phenylacrylamide).
Para-Fluorofentanyl...................... 9812 I
3-Methylfentanyl......................... 9813 I
Alpha-methylfentanyl..................... 9814 I
Acetyl-alpha-methylfentanyl.............. 9815 I
N-(2-fluorophenyl)-N-(1- 9816 I
phenethylpiperidin-4-yl)propionamide.
Acetyl Fentanyl (N-(1-phenethylpiperidin- 9821 I
4-yl)-N-phenylacetamide).
Butyryl Fentanyl......................... 9822 I
Para-fluorobutyryl fentanyl.............. 9823 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-phenethylpiperidin-4-
yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N- 9825 I
phenylacetamide.
Para-chloroisobutyryl fentanyl........... 9826 I
Isobutyryl fentanyl...................... 9827 I
Beta-hydroxyfentanyl..................... 9830 I
Beta-hydroxy-3-methylfentanyl............ 9831 I
Alpha-methylthiofentanyl................. 9832 I
3-Methylthiofentanyl..................... 9833 I
Furanyl fentanyl (N-(1-phenethylpiperidin- 9834 I
4-yl)-N-phenylfuran-2-carboxamide).
Thiofentanyl............................. 9835 I
Beta-hydroxythiofentanyl................. 9836 I
Para-methoxybutyryl fentanyl............. 9837 I
Para-methoxybutyryl fentanyl............. 9838 I
Valeryl fentanyl......................... 9840 I
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-carboxamide.
Cyclopropyl Fentanyl..................... 9845 I
Cyclopentyl Fentanyl..................... 9847 I
Fentanyl related-compounds as defined in 9850 I
21 CFR 1308.11(h).
Amphetamine.............................. 1100 II
Methamphetamine.......................... 1105 II
[[Page 34655]]
Lisdexamfetamine......................... 1205 II
Phenmetrazine............................ 1631 II
Methylphenidate.......................... 1724 II
Amobarbital.............................. 2125 II
Pentobarbital............................ 2270 II
Secobarbital............................. 2315 II
Glutethimide............................. 2550 II
Nabilone................................. 7379 II
1-Phenylcyclohexylamine.................. 7460 II
Phencyclidine............................ 7471 II
4-Anilino-N-phenethyl-4-piperidine (ANPP) 8333 II
Phenylacetone............................ 8501 II
1-Piperidinocyclohexanecarbonitrile...... 8603 II
Alphaprodine............................. 9010 II
Anileridine.............................. 9020 II
Cocaine.................................. 9041 II
Codeine.................................. 9050 II
Etorphine HCl............................ 9059 II
Dihydrocodeine........................... 9120 II
Oxycodone................................ 9143 II
Hydromorphone............................ 9150 II
Diphenoxylate............................ 9170 II
Ecgonine................................. 9180 II
Ethylmorphine............................ 9190 II
Hydrocodone.............................. 9193 II
Levomethorphan........................... 9210 II
Levorphanol.............................. 9220 II
Isomethadone............................. 9226 II
Meperidine............................... 9230 II
Meperidine intermediate-A................ 9232 II
Meperidine intermediate-B................ 9233 II
Meperidine intermediate-C................ 9234 II
Metazocine............................... 9240 II
Methadone................................ 9250 II
Methadone intermediate................... 9254 II
Metopon.................................. 9260 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
Morphine................................. 9300 II
Oripavine................................ 9330 II
Thebaine................................. 9333 II
Dihydroetorphine......................... 9334 II
Levo-alphacetylmethadol.................. 9648 II
Oxymorphone.............................. 9652 II
Noroxymorphone........................... 9668 II
Phenazocine.............................. 9715 II
Thiafentanil............................. 9729 II
Piminodine............................... 9730 II
Racemethorphan........................... 9732 II
Racemorphan.............................. 9733 II
Alfentanil............................... 9737 II
Remifentanil............................. 9739 II
Sufentanil............................... 9740 II
Carfentanil.............................. 9743 II
Tapentadol............................... 9780 II
Bezitramide.............................. 9800 II
Fentanyl................................. 9801 II
Moramide-intermediate.................... 9802 II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances in bulk for distribution to its customers.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-12177 Filed 6-4-20; 8:45 am]
BILLING CODE 4410-09-P
